Skip to content

The platform

The architecture of trust.

The adversarial validation layer between AI-generated science and accountability. Four independent agents audit every brief and return one consensus verdict: PROCEED, DELAY or KILL, before your organization is exposed.

System architecture

One path, five stages, from claim to accountable verdict.

  1. 01

    Input

    A brief, memo or claim enters through Signal Ingestion. Evidence is drawn from regulatory filings, scientific literature, market signals and the FHIN contributor network.

  2. 02

    Analysis

    Cortex carries the analysis across six modules, operating as one verification layer rather than six separate tools.

  3. 03

    Adversarial review

    Four independent agents audit the same material in parallel. None defers to another. Disagreement is retained as signal.

  4. 04

    Verdict

    The four positions reconcile into PROCEED, DELAY or KILL, with a confidence score and full source traceability. Claims that cannot resolve to a source are gated rather than passed.

  5. 05

    Delivery

    Output reaches the decision-maker through the Executive Briefing module or on demand via AIMN:VERDICT. Access tier determines scope of delivery, not the rigour of the audit.

Cortex

Six modules. One verification layer.

Signal Ingestion

Watches for the movements you would otherwise find out about late: a competitor filing, a trial result, a guidance change.

Works from
Regulatory filings, scientific and clinical literature, market and competitive signals.
Produces
Competitor movement alerts.
Example
Illustrative: a competitor’s licensing filing is flagged against the category you monitor.

Scope of delivery follows your access tier.

The audit

Four independent agents. None defers to another.

  • RegulatoryDoes the claim hold against agency guidance?
  • CompetitiveIs it consistent with the landscape?
  • TrialDoes the trial evidence support it?
  • CapitalDo the commercial assumptions survive?
Inputs
Briefs, memos and claims, plus the evidence behind them: regulatory filings, scientific and clinical literature, market and competitive signals.
Outputs
A source-traced verdict with a confidence score, the four independent positions behind it, and a record of what was checked. A decision object, not a summary.
Primary buyer
The person accountable for the decision: biopharma and enterprise biotech teams, investors and capital allocators, sovereign health ministries, and credentialed individual practitioners.
Deployment
Five steps: assess, configure, ingest, activate, then scheduled refresh. Security and compliance posture is documented at /security.

Outputs

Intelligence that arrives before you ask for it.

  • Competitor movement alerts
  • Regulatory shift memos
  • Weekly executive brief
  • Asset comparison summaries
  • Market-belief divergence signals
  • On-demand verdicts through AIMN:VERDICT

AimwellBio is decision-support infrastructure. It is not medical advice, regulatory guidance, legal counsel, or an investment recommendation. All outputs are designed for review by qualified professionals before use in clinical, regulatory, legal, or investment workflows.

AimwellBio, explained

Direct answers to what AimwellBio actually is.

What each component is and the role it performs in the validation layer.

The system

What is AIMN?

AIMN is the ticker symbol for Aimwell Partners Inc., the company that operates AimwellBio. It also prefixes the product lines built on the validation layer: AIMN:VERDICT, the adversarial intelligence engine that returns on-demand entity verdicts, and AIMN:ATLAS. The company and the product namespace share the symbol.

What is Cortex?

Cortex is the intelligence operating system underneath the platform: six modules working as one verification layer: Signal Ingestion, Memory, Regulatory, Market Belief, Executive Briefing, and Private Intelligence. Every Cortex output carries a confidence score and is source-traced back to the evidence behind it.

What is FHIN?

FHIN is the Federated Health Intelligence Network, the contributor and verification layer behind the platform. Credentialed professionals participate in it, and their verified participation is what distinguishes a federated network from an unsourced aggregate. A founding contributor cohort is open.

What are Signal, Shield, Member and Command?

These are access tiers, not separate products. Observer is free for credentialed professionals; Member, Signal, Shield and Command provide progressively broader access to verdicts, monitoring and private intelligence. All tiers operate on the same validation layer; the tier determines scope of access, not the rigour of the audit.

What is a Verdict?

A verdict is the output of the validation layer: PROCEED, DELAY, or KILL, issued with a confidence score and source traceability. It is the reconciliation of four independent audits rather than a single model's opinion, and it is deliberately a decision object rather than a summary: something a person can attach to the decision they are accountable for.

How is AimwellBio different from a general-purpose AI model?

A general-purpose model generates an answer; AimwellBio audits one. The unit of output is a source-traced verdict from four independent reviewers, not a fluent response from a single system. The methodology is published rather than proprietary, and disagreement between reviewers is preserved rather than smoothed into a confident-sounding paragraph.

Get started free → Request access → Compare tiers → Read the Standard → Contact us →

Observer access is free for credentialed professionals. Methodology published as the Adversarial Validation Standard, v1.0 (2026-09). Security and compliance posture: /security.

See how it is deployed.

Assess, configure, ingest, activate, then scheduled refresh.

How it works